169 related articles for article (PubMed ID: 22002622)
1. Nucleotide excision repair gene ERCC1 polymorphisms contribute to cancer susceptibility: a meta-analysis.
Zhang L; Wang J; Xu L; Zhou J; Guan X; Jiang F; Wu Y; Fan W
Mutagenesis; 2012 Jan; 27(1):67-76. PubMed ID: 22002622
[TBL] [Abstract][Full Text] [Related]
2. Association studies of ERCC1 polymorphisms with lung cancer susceptibility: a systematic review and meta-analysis.
Zhu J; Hua RX; Jiang J; Zhao LQ; Sun X; Luan J; Lang Y; Sun Y; Shang K; Peng S; Ma J
PLoS One; 2014; 9(5):e97616. PubMed ID: 24841208
[TBL] [Abstract][Full Text] [Related]
3. Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer.
Zhou W; Liu G; Park S; Wang Z; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):491-6. PubMed ID: 15734977
[TBL] [Abstract][Full Text] [Related]
4. Association of excision repair cross-complimentary group 1 gene polymorphisms with breast and ovarian cancer susceptibility.
Yang F; Mu X; Bian C; Zhang H; Yi T; Zhao X; Lin X
J Cell Biochem; 2019 Sep; 120(9):15635-15647. PubMed ID: 31081240
[TBL] [Abstract][Full Text] [Related]
5. Nucleotide excision repair gene ERCC1 19007T>C polymorphism contributes to lung cancer susceptibility: a meta-analysis.
Xie F; Sun Q; Wu S; Xie X; Liu Z
Genet Test Mol Biomarkers; 2014 Aug; 18(8):591-5. PubMed ID: 25051148
[TBL] [Abstract][Full Text] [Related]
6. Tagging single nucleotide polymorphisms in excision repair cross-complementing group 1 (ERCC1) and risk of primary lung cancer in a Chinese population.
Ma H; Xu L; Yuan J; Shao M; Hu Z; Wang F; Wang Y; Yuan W; Qian J; Wang Y; Xun P; Liu H; Chen W; Yang L; Jin G; Huo X; Chen F; Shugart YY; Jin L; Wei Q; Wu T; Shen H; Huang W; Lu D
Pharmacogenet Genomics; 2007 Jun; 17(6):417-23. PubMed ID: 17502833
[TBL] [Abstract][Full Text] [Related]
7. Association of ERCC1 Polymorphisms with the Risk of Colorectal Cancer: A Meta-Analysis.
Chen J; Sun N; Hu G; Chen X; Jiang J; Wu H; Luo G
Crit Rev Eukaryot Gene Expr; 2017; 27(3):267-275. PubMed ID: 29199611
[TBL] [Abstract][Full Text] [Related]
8. The association of polymorphisms in nucleotide excision repair genes with ovarian cancer susceptibility.
Zhao Z; Zhang A; Zhao Y; Xiang J; Yu D; Liang Z; Xu C; Zhang Q; Li J; Duan P
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29669843
[TBL] [Abstract][Full Text] [Related]
9. Rs3212986 polymorphism, a possible biomarker to predict smoking-related lung cancer, alters DNA repair capacity via regulating ERCC1 expression.
Yu T; Xue P; Cui S; Zhang L; Zhang G; Xiao M; Zheng X; Zhang Q; Cai Y; Jin C; Yang J; Wu S; Lu X
Cancer Med; 2018 Dec; 7(12):6317-6330. PubMed ID: 30453383
[TBL] [Abstract][Full Text] [Related]
10. A meta-analysis identifies ERCC1 gene polymorphism as a predictor of better patient response to treatment with radiochemotherapy.
Li F; Xie X; Ren X; Zhang J
Cancer Chemother Pharmacol; 2016 Jun; 77(6):1183-91. PubMed ID: 27100737
[TBL] [Abstract][Full Text] [Related]
11.
Li B; Shi X; Yuan Y; Peng M; Jin H; Qin D
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29752341
[TBL] [Abstract][Full Text] [Related]
12. Role of common ERCC1 polymorphisms in cisplatin-resistant epithelial ovarian cancer patients: A study in Chinese cohort.
Bao Y; Yang B; Zhao J; Shen S; Gao J
Int J Immunogenet; 2020 Oct; 47(5):443-453. PubMed ID: 32173978
[TBL] [Abstract][Full Text] [Related]
13. Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: a pooled analysis based on 39 reports.
Xu TP; Shen H; Liu LX; Shu YQ
Gene; 2013 Sep; 526(2):265-74. PubMed ID: 23727606
[TBL] [Abstract][Full Text] [Related]
14. Association of ERCC1 polymorphisms (rs3212986 and rs11615) with the risk of head and neck carcinomas based on case-control studies.
Ding YW; Gao X; Ye DX; Liu W; Wu L; Sun HY
Clin Transl Oncol; 2015 Sep; 17(9):710-9. PubMed ID: 26022132
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in the ERCC1 and XPF genes and risk of breast cancer in a Chinese population.
Yang Z; Fang X; Pei X; Li H
Genet Test Mol Biomarkers; 2013 Sep; 17(9):700-6. PubMed ID: 23909490
[TBL] [Abstract][Full Text] [Related]
16. DNA repair gene ERCC1 polymorphisms may contribute to the risk of glioma.
Yuan G; Gao D; Ding S; Tan J
Tumour Biol; 2014 May; 35(5):4267-75. PubMed ID: 24453030
[TBL] [Abstract][Full Text] [Related]
17. Distribution and susceptibility of ERCC1/XPF gene polymorphisms in Han and Uygur women with breast cancer in Xinjiang, China.
Li H; Zhou L; Ma J; Zhu Y; Fan J; Li N; Zheng Y; Sha T; Zhai Z; Ma B; Dai Z
Cancer Med; 2020 Dec; 9(24):9571-9580. PubMed ID: 33067872
[TBL] [Abstract][Full Text] [Related]
18. Association between ERCC1 C8092A and ERCC2 K751Q polymorphisms and risk of adult glioma: a meta-analysis.
Xu Z; Ma W; Gao L; Xing B
Tumour Biol; 2014 Apr; 35(4):3211-21. PubMed ID: 24254311
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in ERCC1 and XPF genes and risk of gastric cancer in an eastern Chinese population.
He J; Xu Y; Qiu LX; Li J; Zhou XY; Sun MH; Wang JC; Yang YJ; Jin L; Wei QY; Wang Y
PLoS One; 2012; 7(11):e49308. PubMed ID: 23166636
[TBL] [Abstract][Full Text] [Related]
20. A Comprehensive Analysis of Influence ERCC Polymorphisms Confer on the Development of Brain Tumors.
Geng P; Ou J; Li J; Liao Y; Wang N; Xie G; Sa R; Liu C; Xiang L; Liang H
Mol Neurobiol; 2016 May; 53(4):2705-14. PubMed ID: 26264164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]